The VEGFR2, COX‐2 and MMP‐2 polymorphisms are associated with clinical outcome of patients with inoperable non‐small cell lung cancer

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0215|137|10|2332-2342

ISSN： 0020-7136

Source： INTERNATIONAL JOURNAL OF CANCER, Vol.137, Iss.10, 2015-11, pp. : 2332-2342

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Survival Outcome of Inoperable Non-Small Cell Lung Cancer Patients Receiving Conventional Dose Epirubicin and Paclitaxel as First-Line Treatment

By  

Oncology, Vol. 68, Iss. 4-6, 2005-08 ,pp. : 350-355

Karger

Access to resources Recommend Favorite

Microtubule affinity‐regulating kinase 2 is associated with DNA damage response and cisplatin resistance in non‐small cell lung cancer

By  

INTERNATIONAL JOURNAL OF CANCER, Vol. 137, Iss. 9, 2015-11 ,pp. : 2072-2082

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cyclooxygenase 2 inhibition in patients with non–small cell lung cancer: Is this still a valid target for therapy?

By  

CANCER, Vol. 121, Iss. 18, 2015-09 ,pp. : 3197-3200

John Wiley & Sons Inc

Access to resources Recommend Favorite

Extra-cranial Stereotactic Radiation Therapy (ESRT) in the treatment of inoperable stage 1 2 non-small-cell lung cancer patients with highly mobile tumours: a literature review

By  

Journal of Radiotherapy in Practice, Vol. 9, Iss. 4, 2010-11 ,pp. : 247-259

Cambridge University Press

Access to resources Recommend Favorite

Relationship between icotinib hydrochloride exposure and clinical outcome in Chinese patients with advanced non–small cell lung cancer

By  

CANCER, Vol. 121, Iss. S17, 2015-09 ,pp. : 3146-3156

John Wiley & Sons Inc

Access to resources Recommend Favorite